[{"id":"0f922648-2605-4a12-9b33-08b5a5febdbe","acronym":"","url":"https://clinicaltrials.gov/study/NCT02146313","created_at":"2021-01-18T09:58:27.690Z","updated_at":"2024-07-02T16:37:09.655Z","phase":"Phase 1","brief_title":"A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer","source_id_and_acronym":"NCT02146313","lead_sponsor":"Genentech, Inc.","biomarkers":" MUC16 • MUC4","pipe":" | ","alterations":" MUC16 expression","tags":["MUC16 • MUC4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MUC16 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e RG7882"],"overall_status":"Completed","enrollment":" Enrollment 35","initiation":"Initiation: 06/22/2014","start_date":" 06/22/2014","primary_txt":" Primary completion: 06/18/2018","primary_completion_date":" 06/18/2018","study_txt":" Completion: 06/18/2018","study_completion_date":" 06/18/2018","last_update_posted":"2018-06-21"}]